packageSitagliptin

sitagliptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sitagliptin is a DPP-4 inhibitor used to lower blood glucose in people with diabetes, including type 2 diabetes and, according to Wikidata, type 1 diabetes and maturity-onset diabetes of the young type 2. It is widely used and authorised in the European Union, available both alone and in combination products with other oral glucose-lowering drugs.

Summary written by glm-5.3-flash from Wikidata Q419832 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sitagliptin
ATC codes:A10BH01
DrugBank:DB01261
PubChem CID:4369359
ChEBI:40237
Wikidata:Q419832
formula:C16H15F6N5O
molar mass:407.318 g/mol (PubChem CID 4369359)
logP:0.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown